What is the latest price of fostamatinib in 2025

Fostamatinib (Fostamatinib) is used to treat people with chronic immune thrombocytopenia (ITP; a persistent condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood). Fotantinib belongs to the kinase inhibitor class of drugs, which work by reducing platelet destruction.

This medication is available as an oral tablet and is usually recommended to be taken twice daily with or without food. Patients should try to take fotantinib at the same time every day and strictly follow their doctor's prescription instructions. If you have any questions, you should consult your doctor or pharmacist and do not adjust the dosage yourself.

During treatment, patients may experience certain side effects, and doctors may adjust the treatment plan based on the patient's response, including reducing the dose, temporarily interrupting, or stopping treatment entirely. Doctors may also decide to terminate treatment if platelet counts do not reach expected levels after 12 weeks of treatment. Therefore, it is important to communicate your personal treatment experience with your doctor so that necessary adjustments and management can be made based on the actual situation. This ensures that patients receive optimal results and safety during treatment.

The current common specifications of fotantinib are100mg*60 tablets and 150mg*60 tablets. The original research version has not yet been launched in China, so its price and medical insurance policy are still unknown. There is a German original version of fotantinib available for sale overseas, and the price per box may range from 20,000 to 40,000 yuan (the price may fluctuate due to exchange rates); it is still relatively expensive. In addition, there are no generic versions of fotantinib available for sale in overseas markets; for patients in need, please consult Yaode Medical Consultants for more information on overseas drug prices and related information.

Reference materials:https://medlineplus.gov/druginfo/meds/a618025.html